{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:18Z","timestamp":1759451958037,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.04.057","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T01:23:32Z","timestamp":1588901012000},"page":"4281-4287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel electrophoretic immunoblot as antigen desorption and quantification method for alum-adjuvanted veterinary rabies vaccines"],"prefix":"10.1016","volume":"38","author":[{"given":"Anna","family":"Morgenroth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Jakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Hanke-Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-3653","authenticated-orcid":false,"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-398X","authenticated-orcid":false,"given":"Conrad","family":"Freuling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Cussler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Duchow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-8568","authenticated-orcid":false,"given":"Max","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.057_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2020.04.057_b0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14760584.2019.1627205","article-title":"Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination","volume":"18","author":"Rupprecht","year":"2019","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.04.057_b0015","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.04.057_b0020","first-page":"195","article-title":"WHO expert consultation on rabies, third report","volume":"1012","author":"World Health Organization","year":"2018","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2020.04.057_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/vr.h4196","article-title":"Rabies: 100 per cent fatal, 100 per cent preventable","volume":"177","author":"Abela-Ridder","year":"2015","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2020.04.057_b0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14760584.2016.1140040","article-title":"Current status and development of vaccines and other biologics for human rabies prevention","volume":"15","author":"Rupprecht","year":"2016","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.04.057_b0035","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1371\/journal.pntd.0000626","article-title":"The feasibility of canine rabies elimination in Africa: dispelling doubts with data","volume":"4","author":"Lembo","year":"2010","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.04.057_b0040","doi-asserted-by":"crossref","first-page":"635-A","DOI":"10.2471\/BLT.16.183012","article-title":"Rabies vaccine stockpile: fixing the supply chain","volume":"94","author":"Abela-Ridder","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.04.057_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpubh.2017.00103","article-title":"The road to dog rabies control and elimination-what keeps us from moving faster?","volume":"5","author":"Fahrion","year":"2017","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2020.04.057_b0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biologicals.2017.05.006","article-title":"Modern science for better quality control of medicinal products \u201cTowards global harmonization of 3Rs in biologicals\u201d: The report of an EPAA workshop","volume":"48","author":"Schutte","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.04.057_b0055","series-title":"Laboratory techniques in rabies: the NIH test for potency. Monograph series","first-page":"279","author":"Seligmann","year":"1973"},{"key":"10.1016\/j.vaccine.2020.04.057_b0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biologicals.2014.04.001","article-title":"Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers","volume":"42","author":"Schiffelers","year":"2014","journal-title":"Biologicals"},{"unstructured":"Russell W. M. S., L. BR. The principles of humane experimental technique. methuen Reprinted 1992: Universities Federation for Animal Welfare; 1959.","key":"10.1016\/j.vaccine.2020.04.057_b0065"},{"key":"10.1016\/j.vaccine.2020.04.057_b0070","first-page":"37","article-title":"Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use","volume":"2010","author":"Kramer","year":"2010","journal-title":"Pharmeuropa Bio & Sci Notes"},{"key":"10.1016\/j.vaccine.2020.04.057_b0075","first-page":"211","article-title":"Regulatory acceptance and use of serology for inactivated veterinary rabies vaccines","volume":"32","author":"Schiffelers","year":"2015","journal-title":"Altex"},{"unstructured":"Council of Europe. Monograph 0451: Rabies vaccine (inactivated) for veterinary use. In: The European Pharmacopoeia 9.5. Strasbourg; 2018.","key":"10.1016\/j.vaccine.2020.04.057_b0080"},{"key":"10.1016\/j.vaccine.2020.04.057_b0085","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2016.12.039","article-title":"Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study","volume":"35","author":"Morgeaux","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.057_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2019.05.004","article-title":"Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA","author":"Toinon","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.04.057_b0095","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1038\/s41598-017-07687-7","article-title":"A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"doi-asserted-by":"crossref","unstructured":"Fox CB, Kramer RM, Barnes V L, Dowling QM, Vedvick TS. Working together: interactions between vaccine antigens and adjuvants. 2013;1:7\u201320.","key":"10.1016\/j.vaccine.2020.04.057_b0100","DOI":"10.1177\/2051013613480144"},{"unstructured":"Council of Europe. Monograph 50214: substitution of in vivo method(s) by in vitro method(s) for the quality control of vaccines. In: The European Pharmacopoeia 10.0. Strasbourg; 2020.","key":"10.1016\/j.vaccine.2020.04.057_b0105"},{"key":"10.1016\/j.vaccine.2020.04.057_b0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.biologicals.2012.07.011","article-title":"In vitro antigen ELISA for quality control of tetanus vaccines","volume":"40","author":"Coombes","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.04.057_b0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2009.09.002","article-title":"Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines","volume":"350","author":"Coombes","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2020.04.057_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0166-0934(89)90104-3","article-title":"In vitro assessment of viral antigen content in inactivated aluminum hydroxide adjuvanted vaccines","volume":"25","author":"Katz","year":"1989","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.04.057_b0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0264-410X(95)80009-3","article-title":"Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants","volume":"13","author":"Al-Shakhshir","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.057_b0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ab.2011.07.012","article-title":"Flow cytometry: an alternative method for direct quantification of antigens adsorbed to aluminum hydroxide adjuvant","volume":"418","author":"Ugozzoli","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2020.04.057_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jim.2009.03.005","article-title":"Development of a direct alhydrogel formulation immunoassay (DAFIA)","volume":"344","author":"Zhu","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2020.04.057_b0140","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.vaccine.2015.06.091","article-title":"A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine","volume":"33","author":"Sigoillot-Claude","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.057_b0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jviromet.2010.12.010","article-title":"Establishment and validation of an ELISA for the quantitation of HBsAg in recombinant hepatitis B vaccines","volume":"172","author":"Costa","year":"2011","journal-title":"J Virol Methods."},{"key":"10.1016\/j.vaccine.2020.04.057_b0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(01)00317-6","article-title":"The role of the adsorption process for production and control combined adsorbed vaccines","volume":"20","author":"Matheis","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.057_b0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vaccine.2011.11.025","article-title":"Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer","volume":"30","author":"Zhu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.057_b0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.057_b0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.04.057_b0170","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.04.057_b0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biologicals.2010.12.001","article-title":"The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs","volume":"39","author":"De Mattia","year":"2011","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:24Z","timestamp":1759401864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":35,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20305612"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel electrophoretic immunoblot as antigen desorption and quantification method for alum-adjuvanted veterinary rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}